Oligonucleotide Therapeutics

Oligonucleotides modulate gene-specific expression within cells and
can be used to identify genes involved in diseases. Continuing
developments in oligonucleotide research have begun to unleash
their potential as therapeutic agents.

Contributions from basic researchers in molecular biology, cell
biology, nucleic acid chemistry, pharmacology, and applied
therapeutics present new technologies in the field of
oligonucleotide research and are organized into sections focusing
on small RNA-mediated gene silencing, miRNA, oligonucleotide
chemistry and new technologies, delivery strategies,
immunorecognition of nucleic acids, drug and therapeutic
development, aptamers and other evolved systems, and preclinical
models and clinical programs.

NOTE: Annals volumes are available for sale as individual
books or as a journal. For information on institutional journal
subscriptions, please visit href="http://www.blackwellpublishing.com/nyas">www.blackwellpublishing.com/nyas.

ACADEMY MEMBERS: Please contact the New York Academy of
Sciences directly to place your order (href="http://www.nyas.org/">www.nyas.org).
Members of the New York Academy of Science receive full-text access
to the Annals online and discounts on print volumes. Please visit
href="http://www.nyas.org/MemberCenter/Join.aspx">http://www.nyas.org/MemberCenter/Join.aspx
for more information about becoming a member.